Since glutamine (Gln) is considered a major fuel for small bowel (SB), extensive SB resection could alter whole body Gln metabolism in vivo. Very few data are available on Gln metabolism in infants.
A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs). This is an ASCO Meeting Abstract from the 2020 Gastrointestinal Cancers Symposium.
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Immediate immunoprophylaxis after curative ileo-colonic resection did not reduce the rate of early ...
TOKYO, June 21, 2021 /PRNewswire/ -- Researchers at Keio University, Japan, offer new insights into the adaptive immune system of the small intestine for new perspectives on host-microorganism ...
Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2008 ASCO Annual Meeting. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results